Difference between revisions of "Part:BBa K1202105"

 
 
Line 1: Line 1:
−
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K1202105 short</partinfo>
 
<partinfo>BBa_K1202105 short</partinfo>
  
−
This complex has two part.
+
TAT-Apoptin was designed to induce programmed cell death (apoptosis) in cancer cells, selectively.  TAT signal peptide added to direct apoptin into cancer cells.  
−
Tat : Tat protein putting in this complex to the cancer cell through dissolving cell membrane.
+
 
−
Apoptin : Apoptin is forcing cancer cells to apoptosis when apoptin enter into cell.
+
Apoptin is a novel prospective cancer drug which induces programmed cell death (apoptosis) phase of normal cell life cycle in cancer cells, selectively. The exact mechanism of apoptin is not understood, yet. But, the efficiency and results of the function are researched and pose promising hopeful results for efficient cancer therapy.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Latest revision as of 00:30, 5 October 2013

TAT-Apoptin: Cancer killing peptide

TAT-Apoptin was designed to induce programmed cell death (apoptosis) in cancer cells, selectively. TAT signal peptide added to direct apoptin into cancer cells.

Apoptin is a novel prospective cancer drug which induces programmed cell death (apoptosis) phase of normal cell life cycle in cancer cells, selectively. The exact mechanism of apoptin is not understood, yet. But, the efficiency and results of the function are researched and pose promising hopeful results for efficient cancer therapy.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 7
    Illegal NheI site found at 30
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 348
  • 1000
    COMPATIBLE WITH RFC[1000]